MS Group Praises New Drug Despite High Price Tag April 03, 2017By Christine BlankWhy a drug that costs $65,000 a year is making patient groups happy. GSK Issues Voluntary Recall April 03, 2017By Nicholas HammNearly 600,000 inhalers are being recalled. EpiPen and EpiPen Jr. Recalled: Recall Expanded from Europe and AsiaTwo previous reports of device failures lead EpiPen maker to expand recall to the United States. As More Canadian Provinces Mandate Error Reporting, U.S. Experts Call for Similar Laws March 30, 2017By Nicholas HammOntario joins Nova Scotia in making medication dispensing error reporting mandatory, but no states have enacted similar laws. What to do About Rising Health-Care Costs? March 29, 2017By Nicholas HammTaking a clear-eyed look at the cost of health care can reduce waste. What’s in the Specialty Pharmacy Pipeline?Biosimilars, cancer drugs, and orphan drugs are heading towards FDA approval in 2017. New York City Program Aims to Slash Opioid Deaths March 27, 2017By Christine BlankWhat New York City is doing to curb the opioid epidemic.